211At-labelled anti-CD20 mAb(Fred Hutchinson Cancer Research Center)
N/A
Report date: 2025/11/24 17:27:35
Base Information
Drug Name211At-labelled anti-CD20 mAb(Fred Hutchinson Cancer Research Center)
Drug Alias Name
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research CenterUniversity Of WashingtonUniversity of Gothenburg
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniversity Of WashingtonFred Hutchinson Cancer Research CenterUniversity of Gothenburg
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A